相关实验视频
Updated: Jul 24, 2025
10:44
Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
Published on: February 22, 2015
10.3K
多发性硬化病原和针对性治疗方法的更新
Eleni S Vasileiou1, Kathryn C Fitzgerald2,3
1Department of Neurology, Johns Hopkins University, Baltimore, MD, USA.
Current allergy and asthma reports
|July 4, 2023
概括
本综述更新了多发性硬化症 (MS) 的进展. 像布鲁顿氨酸激酶 (BTK) 抑制剂等新疗法以及对爱斯坦-巴尔病毒 (EBV) 的洞察力为管理这种中枢神经系统疾病提供了希望.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 多发性硬化症 (MS) 是年轻人非创伤性残疾的主要原因.
- 它的特征是中枢神经系统 (CNS) 的炎症和退化.
- 了解疾病机制的进步推动了治疗的发展.
研究的目的:
- 提供关于多发性硬化症的科学进展的全面更新.
- 突出MS的新兴治疗方法.
- 综述MS病理生理学和最近的治疗干预措施.
主要方法:
- 关于当前科学进步的文献综述.
- 对新兴治疗策略的分析.
- 对MS病理生理学和治疗的研究综合.
主要成果:
- 布鲁顿氨酸激酶 (BTK) 抑制剂显示出作为一种新的免疫调节治疗的前景.
- 埃普斯坦-巴尔病毒 (EBV) 越来越被认为是MS的关键因素.
- 研究正在扩大,以了解MS病变的非炎症驱动因素.
结论:
- 多发性硬化症的发病过程复杂,需要多方面的干预策略.
- 最近的治疗进展准了MS的炎症成分.
- 持续的研究对于解决MS的知识差距至关重要.
相关概念视频
01:15Parkinson's Disease: Overview
606
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
606
01:20Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K